Last updated: July 12, 2026

Application No. 19/298,995

Untitled Application

Unknown

Filed

Priority

Dec 18, 2019 — provisional 62/949,661 +2 more

Examiner

BOWLES, DAVID PAUL

Art Unit

Tech Center

ELI LILLY AND COMPANY

Assignee

Eli Lilly and Company

OA Round

1 (Non-Final)

Interview Optional

— +22.3% interview lift. Examiner has a relatively high allowance rate (71%); +22.3% interview lift. A written response may suffice.

Based on 31 resolved cases, 2023–2026

Examiner Intelligence

BOWLES, DAVID PAUL View full profile →

Grants 71% — above average

Career Allowance Rate

22 granted / 31 resolved

+11.0% vs TC avg

Strong +22% interview lift

Without

With

+22.3%

Interview Lift

resolved cases with interview

Typical timeline

3y 5m

Avg Prosecution

35 currently pending

Career history

Total Applications

across all art units

Statute-Specific Performance

§103

34.0%

-6.0% vs TC avg

§102

9.2%

-30.8% vs TC avg

§112

27.0%

-13.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 31 resolved cases

Prosecution Timeline

May 19, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/470,988

Patent 12648942

METHOD FOR TREATING ACUTE ISCHEMIC STROKE

2y 8m to grant Granted Jun 09, 2026

17/915,847

Patent 12629405

EZRIN PEPTIDE 1 FOR USE IN A METHOD OF TREATING COVID-19

3y 7m to grant Granted May 19, 2026

19/071,109

Patent 12594326

COMPOSITIONS OF GLP-1 PEPTIDES AND PREPARATION THEREOF

1y 1m to grant Granted Apr 07, 2026

17/820,251

Patent 12590134

GLP-1 AGONIST POLYPEPTIDE COMPOUND AND SALT THEREOF, SYNTHESIS METHOD THEREFOR AND USE THEREOF

3y 7m to grant Granted Mar 31, 2026

17/617,670

Patent 12576025

PHARMACEUTICAL PARENTERAL COMPOSITION OF DUAL GLP1/2 AGONIST

4y 3m to grant Granted Mar 17, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

71%

Grant Probability

93%

With Interview (+22.3%)

3y 5m

Median Time to Grant

Low

PTA Risk

Based on 31 resolved cases by this examiner. Grant probability derived from career allowance rate.